<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04926857</url>
  </required_header>
  <id_info>
    <org_study_id>MDT20024</org_study_id>
    <nct_id>NCT04926857</nct_id>
  </id_info>
  <brief_title>DEFINE AFib (Atrial Fibrillation)</brief_title>
  <acronym>DEFINE AFib</acronym>
  <official_title>DEFINE AFib Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      DEFINE AFib is a prospective, observational, non-significant risk post-market clinical study&#xD;
      administered to patients via the Medtronic Discovery app platform. This study will enroll&#xD;
      approximately 5,000 patients in the United States who have a Reveal LINQ or LINQ II ICM (or&#xD;
      future market-released LINQ devices) and an Apple® iPhone® with iOS version 13 or higher.&#xD;
      Interested participants will be screened through the Medtronic Discovery app and those&#xD;
      eligible will complete an app-based informed consent. Participants will receive&#xD;
      health-focused and quality of life surveys at variable timepoints. DEFINE AFib will measure&#xD;
      healthcare interactions using administered surveys to identify said interactions. The&#xD;
      Medtronic Discovery app will provide participants with a summary of their ICM data.&#xD;
      Participants will be followed up to 5 years or to the end of their ICM service life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2021</start_date>
  <completion_date type="Anticipated">August 2028</completion_date>
  <primary_completion_date type="Anticipated">June 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Healthcare Utilization where AF was a reason or a suspected reason for the healthcare interaction.</measure>
    <time_frame>Through study completion (2 years of enrollment, up to 5 years of follow-up)</time_frame>
    <description>Primary objective is to evaluate whether summary and episodic measurements collected by market-released LINQ ICMs are able to predict increased AF-related healthcare utilization (HCU), which are confirmed healthcare visits in the inpatient hospital, outpatient hospital, clinic/office, emergency department, or other care location (including remote visits) where AF was a reason or suspected reason for healthcare interaction.</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-Interventional</intervention_name>
    <description>Non-Interventional</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Atrial Fibrillation and a LINQ device&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Patients with a LINQ ICM who have a self-reported history of AF and who have received&#xD;
             an ICM for the following device-logged indications, categorized into the following&#xD;
             discrete groups:&#xD;
&#xD;
               -  Stroke: Cryptogenic stroke indication&#xD;
&#xD;
               -  AF management: AF management and post-ablation management indications&#xD;
&#xD;
               -  Suspected AF: Suspected AF and palpitations indications&#xD;
&#xD;
          -  Individual Access and ability to use an Apple iPhone® compatible with Medtronic's&#xD;
             research app (iOS® v. 13.X or higher)&#xD;
&#xD;
          -  Patient is willing and able to comply with the protocol, including CareLink&#xD;
             transmissions (requires adequate connectivity), remotely administered instructions,&#xD;
             and remote survey participation&#xD;
&#xD;
          -  Self-reported virtual CHA2DS2-VASc score ≥2 for men and ≥3 for women&#xD;
&#xD;
          -  Patient is 22 years of age or older&#xD;
&#xD;
          -  Located in the United States, with CareLink managed through servers located in United&#xD;
             States (50 states or District of Columbia)&#xD;
&#xD;
          -  Valid email address from self-report at enrollment&#xD;
&#xD;
          -  Patient must be able to read and write in English&#xD;
&#xD;
        Exclusion Criteria Patients with &gt; 24 months elapsed time from recorded LINQ device implant&#xD;
        or &gt; 48 months elapsed from recorded LINQ II implant date&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nancy Mcclelland, RN, BSN, CHFN</last_name>
    <phone>17635261284</phone>
    <email>nancy.l.mcclelland@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cody Johnson, PhD</last_name>
    <phone>17635262299</phone>
    <email>cody.c.johnson@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Saint Joseph Heritage Hospital</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carrie Mirza, Study Coordinator</last_name>
      <phone>(949) 364-3612 x1262</phone>
      <email>carrie.mirza@stjoe.org</email>
    </contact>
    <investigator>
      <last_name>Jay Tiongson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Desert Heart Rhythm Consultants</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Zaragoza, Study Coordinator</last_name>
      <phone>760-883-1600</phone>
      <email>dhrcoffice@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hetal Bhakta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Electrophysiology Associates</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462-6614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LaMonica Brown, Study Coordinator</last_name>
      <phone>561-420-1374</phone>
      <email>monie.brown97@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Robert Fishel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiac Arrhythmia Service</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Johnston, Study Coordinator</last_name>
      <phone>561-392-9781</phone>
      <email>s.johnston@backonrhythm.com</email>
    </contact>
    <investigator>
      <last_name>Martin E Kloosterman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HCA Healthcare</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Odum, Study Coordinator</last_name>
      <phone>(478) 765-4192</phone>
      <email>craig.odum@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Dhanunjaya Lakkireddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stormont Vail Health Cotton O'Neil Clinical Research Center</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Phipps, Study Coordinator</last_name>
      <phone>(785) 354-0553</phone>
      <email>ashley.phipps@stormontvail.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Vaglio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Fisher, Study Coordinator</last_name>
      <phone>856-968-7472</phone>
      <email>fisher-claire@cooperhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Andrea Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450-2726</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliany Mendoza, Study Coordinator</last_name>
      <phone>201-447-8453</phone>
      <email>emendoz@valleyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Suneet Mittal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huntington Hospital</name>
      <address>
        <city>Huntington</city>
        <state>New York</state>
        <zip>11743</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Hubert, Study Coordinator</last_name>
      <phone>631-547-7191</phone>
      <email>jhubert@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Maccaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>White Plains Hospital Medical Center</name>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Ferrara, Study Coordinator</last_name>
      <phone>914-849-2690</phone>
      <email>mferrara3@wphospital.org</email>
    </contact>
    <investigator>
      <last_name>James Peacock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyse Seckens, Study Coordinator</last_name>
      <phone>919-681-8879</phone>
      <email>elyse.seckens@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Piccini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital Research Foundation</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Myers, Study Coordinator</last_name>
      <phone>405-608-1284</phone>
      <email>jmyers@okheart.com</email>
    </contact>
    <investigator>
      <last_name>Gregory Vanzant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension Seton Heart Institute Clinical Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee Shadrach, Study Coordinator</last_name>
      <phone>512-324-3434</phone>
      <email>aimee.blake@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Mauricio Hong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Saint Joseph Medical Center</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Key, Study Coordinator</last_name>
      <phone>360-734-2700</phone>
      <email>lkey@peacehealth.org</email>
    </contact>
    <investigator>
      <last_name>Michel Barakat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

